Anteris Technologies Ltd (AVR.AX)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 7 | 8 | 5 | 4 | 3 | 2 | 3 | - |
| Operating profit | $m | -94 | -128 | ||||||
| Net profit | $m | -15 | -23 | -44 | -67 | -76 | -94 | -125 | -97 |
| EPS reported | $ | -2.61 | -2.60 | ||||||
| Operating cashflow per share | $ | -2.16 | -0.75 | ||||||
| Capex per share | $ | 0.05 | 0.01 | ||||||
| FCF per share | $ | -2.21 | -0.76 | ||||||
| Free cash flow | $m | -80 | -69 | ||||||
| Net debt | $m | -13 | -257 | ||||||
| Book value equity | $m | -0 | - | ||||||
| Book value per share | $ | -0.01 | 2.79 | ||||||
| Number of shares | m | 36.06 | 90.21 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | -2,970.30 | 3.10 | ||||||
| P/S LTM | x | 144.40 | 98.69 | ||||||
| P/FCF LTM | x | -3.46 | -4.01 | ||||||
| EV/EBITDA LTM | x | -2.88 | -2.11 | ||||||
| EV/Sales LTM | x | 139.02 | 210.03 | ||||||
| Earnings Yield LTM | % | -34.08% | -16.09% | ||||||
| FCF Yield | % | -28.87% | -24.96% | ||||||
| Quality | |||||||||
| ROE | % | +101230.11% | -99.78% | ||||||
| ROIC | % | -42.56% | -50.15% | ||||||
| Operating margin | % | -49.08% | -45.75% | ||||||
| Gross margin | % | +70.26% | +72.55% | ||||||
| FCF/Sales | % | -4169.21% | -2462.79% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -29.23% | +3.55% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -34.95 | -20.74 | ||||||
| Net Debt/EBITDA | x | 0.11 | 2.01 | ||||||
| EBIT/Net interest | x | -1,286.22 | -12,805.42 | ||||||
| Net debt/market cap | % | +0.01% | +0.05% | ||||||
| Net debt/Equity | x | 134.82 | - | ||||||
| Gross debt/equity | x | -24.54 | - | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Anteris Technologies Ltd is a firm specializing in the structural heart domain. It is responsible for the production and distribution of ADAPT, a product based on regenerative tissue technology. The company is also actively involved in advancing DurAVR™, an innovative 3D single-component aortic valve specifically designed for treating aortic stenosis. Additionally, Anteris allocates resources to the research and development of regenerative medicines. Founded in 1999, the enterprise was formerly known as Admedus Limited until it rebranded to Anteris Technologies Ltd in May 2020. Its primary operations are conducted from its base in Toowong, Australia.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Anteris Technologies Ltd is a firm specializing in the structural heart domain. It is responsible for the production and distribution of ADAPT, a product based on regenerative tissue technology. The company is also actively involved in advancing DurAVR™, an innovative 3D single-component aortic valve specifically designed for treating aortic stenosis. Additionally, Anteris allocates resources to the research and development of regenerative medicines. Founded in 1999, the enterprise was formerly known as Admedus Limited until it rebranded to Anteris Technologies Ltd in May 2020. Its primary operations are conducted from its base in Toowong, Australia.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free